"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links."
And just like that, the Spring/Summer 2027 season is coming to a close. Paris Fashion Week has officially begun, kicking off the fourth and final calendar of shows this September. Following New York City, London, and Milan, the French capital is welcoming a flurry of industry professionals and front-row stars alike, all eager to see what's next for our favorite designers.
The schedule started off strong on Monday, with a lineup that opened with 2026 LVMH Prize winner Julie Kegels and closed with avant-garde, industry-favorite Matières Fécales. Rihanna was spotted at the latter, making a grand, fashionably-late entrance in a gold tinsel two-piece, while fellow A-listers—Jennifer Lawrence, Tate McRae, Kendall Jenner with Jacob Elordi, Katie Holmes with Jason Bard Yarmosky, Alexa Chung, and Gabbriette—settled into their hotels and toasted the week ahead at parties and dinners galore.
On Tuesday, Jonathan Anderson sat the likes of Rosalía, Jennifer Lawrence, Anya Taylor-Joy, Cynthia Erivo, Greta Lee, Eileen Gu, Mia Goth, Ejae, and Karlie Kloss front row at his presentation for Christian Dior. Maison Margiela and Saint Laurent followed suit later that evening.
On Wednesday, the Row, Balmain, Dries Van Noten, Stella McCartney, Vaquera, Acne Studios, and Tom Ford welcomed more celebrity sightings, and as the week continues, so will Chloé, Balenciaga, Schiaparelli, Loewe, Givenchy, Victoria Beckham, Vivienne Westwood, Miu Miu, Valentino, Mugler, Jean Paul Gaultier, Chanel, and more. The season will wrap on Tuesday, October 6, with Louis Vuitton.

#jennifer #season #front

Sean "Diddy" Combs may not be getting out of prison as soon as expected after a Dateline segment this week detailed the luxe lifestyle the rap mogul has allegedly built behind bars, complete with a team of fellow inmates treated like his personal staff.
Since arriving at Fort Dix in October 2025 after more than a year at the Metropolitan Detention Center in Brooklyn, Combs has seen his projected release date bounce around the front half of the 2028 calendar, shifting several times between January and June. It now stands at Jan. 21, 2028. In that time, he has entered a drug rehabilitation program at the New Jersey facility, has been involved in a fight with another inmate, and violated several prison rules while serving a 50-month sentence for Mann Act violations.
More from The Hollywood Reporter
Tupac Murder Trial Highlights a Persistent Diddy Conspiracy Theory
Tupac's Murder Case Heads to Trial, 30 Years After Rap Icon's Death

#murder #prison #sean

Stars, patrons and fashionistas descended upon Lincoln Center Thursday night for the annual New York City Ballet Fall Fashion Gala. Now in its 14th year, the gala has become one of the fall social calendar's most anticipated events, not only for a night of dance but for the couture costumes as well.
Guests in attendance included Sarah Jessica Parker, the gala's founding chair, as well as Stevie Nicks, Julia Fox, Fran Drescher, Andy Cohen, Nicole Ari Parker, Bridget Everett and more who promenaded down the red carpet and onto the plaza for ***** tails by the fountain before the supper ball.
More from WWD
New York Magazine Celebrates First Men's Style Issue With Mike Faist, Brandon Flynn and More
Inside Gianvito Rossi's Joyful 20th Anniversary Party in Milan + What's Ahead for Spring 2027

#parker #fall #gala

Meghan Markle is giving fans a casual glimpse behind the scenes as she rolls out her latest holiday project, and her fresh-faced appearance is getting almost as much attention as what she has been working on. The ******* ss of Sussex appeared makeup-free in an Instagram Story shared on October 1, offering a relaxed look at preparations for the first-ever Advent calendar from her lifestyle brand, As Ever.
The short video showed Meghan riding in a golf cart alongside Jonathan Grahm, creative director and chief chocolatier of Compartés. According to InStyle, the footage appears to have been filmed around Meghan and Prince Harry's Montecito property in California.
Prince Harry and Meghan Markle's Montecito estate (@ Grosby Group)
Meghan kept things casual. She appeared fresh-faced in a baseball cap and sweatshirt while smiling for the camera, creating a candid contrast to the more glamorous promotional images accompanying the new holiday release.
Meghan Markle fresh-faced appearance (@ Meghan Markle)

#holiday #appearance

Meghan Markle's As Ever online shop has launched a $148 advent calendar—averaging $6 per chocolate in it—inspired by her Montecito home and garden despite having moved to Britain in August.
However, the Duke and ****** ss of Sussex did not sell their mansion in Santa Barbara when they relocated to the U.K. and may choose to spend Christmas there.
A press release says the calendar includes "24 handcrafted chocolates, one for each day leading up to the holiday, with flavors drawing from As ever favorites like Strawberry, Raspberry, Blackberry, and Orange Marmalade, plus a special chocolate finished with Meghan's own Flower Sprinkles.
"Every detail was considered with care, including countdown numbers hand-painted in Meghan's own penmanship using edible gold ****** er."
The advent calendar is a partnership with Los Angeles chocolatier Compartés and goes on sale on October 1.

#britain #duke

Meghan Markle's As ever brand and Los Angeles chocolatier Compartés unveiled a limited-edition Advent calendar
The holiday countdown features imagery of Meghan and Prince Harry's California home decked out for Christmas
In new videos shared on Instagram Stories, Meghan gave a glimpse of her preparing for the holiday calendar in June
Meghan Markle is already counting down to Christmas!
The ****** ss of Sussex's As ever brand and Los Angeles chocolatier Compartés unveiled a limited-edition Advent calendar on Oct. 1. The $148 calendar features 24 chocolates, with flavors such as strawberry, raspberry, blackberry and orange marmalade — plus a special chocolate that incorporates Meghan's flower sprinkles.

#compart

On August 5, Cencora (NYSE:COR) reported results for its fiscal third quarter, which closed on June 30, and the headline numbers looked clean. Revenue rose 5.1% to $84.8 billion, adjusted earnings per share climbed 12.0% to $4.48, and management raised its full-year adjusted EPS outlook to $17.75 to $17.95. The company also repurchased $1 billion of its own stock during the quarter. But the profit story has moving parts, and a few of them pull in opposite directions.
Start with the gap between profit growth and sales growth. Adjusted operating income rose 17.0% while revenue grew only 5.1%. Much of the help came from gross profit, which jumped 23.2% on an adjusted basis as both segments contributed and the OneOncology acquisition in February lifted margins in the US business. In plain terms, adjusted gross margin widened 61 basis points to 4.16%, so the company keeps more gross profit from every dollar it sells.
The strength was not confined to one corner, either. US Healthcare Solutions grew operating income 15.9% on higher pharmaceutical sales and the OneOncology deal, while specialty volume to health systems and physician groups lifted its revenue. International Healthcare Solutions did better still, with operating income up 20.8% on strength in European distribution and global specialty logistics. Management also put cash to work, completing in one quarter the $1 billion of buybacks it had expected to finish by the close of calendar 2026. The board declared a $0.60 quarterly dividend as well, payable August 31, to holders of record on August 14.
Growth is costing more than it first appears. Adjusted operating expenses jumped 26.8%, faster than adjusted gross profit, because OneOncology brought expenses along with its profits. Even so, adjusted operating income amounts to just 1.46% of revenue, a thin cushion on a business this large. Financing adds weight too. Cencora funded part of the purchase with new senior notes plus variable-rate term loans, and net interest expense rose $58.9 million from a year earlier.
The sales mix carries its own drag. GLP-1 drugs for diabetes and weight loss are adding to revenue, but they earn lower gross margins, so each dollar of that growth is worth less to profit. Meanwhile, an oncology customer Cencora lost in 2025, and lower sales to a large mail order customer both held back US revenue, as did lower manufacturer prices on some brand pharmaceuticals. Cencora is also exploring strategic alternatives for a group of other businesses, and its April divestiture of US Consulting Services trimmed consulting sales.

#adjusted #revenue #august

Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
The U.S. Bank Shield™ Visa® Visa Card is a 0% APR card with a lengthy intro period lasting 21 billing cycles for both balance transfers and new purchases. It's a great option for debt payoff, but you may also want to consider its long-term value before you apply.
$20 annual statement credit: Earn up to $20 as an annual statement credit when you make purchases with your card over 11 consecutive calendar months.
Cell phone protection: Worth up to $600 per claim (with a $100 deductible) in case of theft or damage to your phone. You can make one claim every 12 months and must pay your monthly cell phone bill with your card to qualify.

#credit

The big day that seemingly everyone had circled on their calendar for weeks, Sept. 16, lived up to the hype.
On Wednesday, Sept. 16, Fed Chair Kevin Warsh and the 11 other voting members of the Federal Open Market Committee (FOMC) raised the federal funds target rate by 25 basis points to a new range of 3.75%-4.00%. The first interest rate hike since July 2023 wasn't well-received by Wall Street, with the time-tested Dow Jones Industrial Average (DJINDICES:^DJI) tumbling more than 1%, and the broad-based S&P 500 (SNPINDEX:^GSPC) and innovation-powered Nasdaq Composite (NASDAQINDEX:^IXIC) edging lower.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
While Warsh's and the FOMC's actions are bound to raise questions and incite worry on Wall Street, nearly 36 years of history make clear what comes next for stocks.
Fed Chair Kevin Warsh and the FOMC just kicked off the first rate-hiking cycle in three years. Image source: Official Federal Reserve Photo.

#years #sept #chair

On August 5, Cencora (NYSE:COR) reported results for its fiscal third quarter, which closed on June 30, and the headline numbers looked clean. Revenue rose 5.1% to $84.8 billion, adjusted earnings per share climbed 12.0% to $4.48, and management raised its full-year adjusted EPS outlook to $17.75 to $17.95. The company also repurchased $1 billion of its own stock during the quarter. But the profit story has moving parts, and a few of them pull in opposite directions.
Start with the gap between profit growth and sales growth. Adjusted operating income rose 17.0% while revenue grew only 5.1%. Much of the help came from gross profit, which jumped 23.2% on an adjusted basis as both segments contributed and the OneOncology acquisition in February lifted margins in the US business. In plain terms, adjusted gross margin widened 61 basis points to 4.16%, so the company keeps more gross profit from every dollar it sells.
The strength was not confined to one corner, either. US Healthcare Solutions grew operating income 15.9% on higher pharmaceutical sales and the OneOncology deal, while specialty volume to health systems and physician groups lifted its revenue. International Healthcare Solutions did better still, with operating income up 20.8% on strength in European distribution and global specialty logistics. Management also put cash to work, completing in one quarter the $1 billion of buybacks it had expected to finish by the close of calendar 2026. The board declared a $0.60 quarterly dividend as well, payable August 31, to holders of record on August 14.
Growth is costing more than it first appears. Adjusted operating expenses jumped 26.8%, faster than adjusted gross profit, because OneOncology brought expenses along with its profits. Even so, adjusted operating income amounts to just 1.46% of revenue, a thin cushion on a business this large. Financing adds weight too. Cencora funded part of the purchase with new senior notes plus variable-rate term loans, and net interest expense rose $58.9 million from a year earlier.
The sales mix carries its own drag. GLP-1 drugs for diabetes and weight loss are adding to revenue, but they earn lower gross margins, so each dollar of that growth is worth less to profit. Meanwhile, an oncology customer Cencora lost in 2025, and lower sales to a large mail order customer both held back US revenue, as did lower manufacturer prices on some brand pharmaceuticals. Cencora is also exploring strategic alternatives for a group of other businesses, and its April divestiture of US Consulting Services trimmed consulting sales.

#profit #operating #Growth #august

Medicare's two-year income lookback makes age 63 the last year a Roth conversion won't directly raise your Medicare premiums at 65.
Married couples can convert roughly $133,000 annually within the 22% bracket, but crossing the $218,000 IRMAA threshold triggers surcharges for both spouses.
Delaying Social Security to 70 preserves low-income years for conversions, since every dollar of benefits claimed adds an invisible marginal rate on top of conversion income.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
A 63-year-old with $1.4 million in a traditional 401(k) has a narrower Roth conversion window than the calendar suggests. Medicare enrollment at 65 uses a two-year lookback on modified adjusted gross income, which means the conversion executed at 63 is the one that sets Medicare premiums at 65. The real deadline arrives earlier than most people expect.

#income #roth #lookback

On September 9, 2026, Reuters reported that Meta Platforms, Inc. (NASDAQ:META) rolled out Muse, a long-touted AI agent that can autonomously send emails, sell a car, and book travel on a person's behalf, despite internal concerns among Meta's own employees that the technology mismanages access to sensitive personal data. The agent is modeled on the open-source system OpenClaw and available initially only in the U.S. through a dedicated app or WhatsApp. It is designed to access apps across email, calendar, payments, health, shopping, and smart-home categories as the centerpiece of CEO Mark Zuckerberg's "personal superintelligence" strategy.
Muse could give Meta Platforms, Inc. (NASDAQ:META) a new revenue stream beyond advertising by turning its massive user base into paying AI customers. The company launched Muse with a free tier and $20 and $100 monthly subscription options for heavier users. The agent can handle tasks such as sending emails, selling items, and booking travel. It gives Meta a direct way to monetize AI capabilities and diversify its revenue base.
The new AI agent could help Meta generate returns from its enormous AI infrastructure investment. Meta expects AI infrastructure spending to exceed $130 billion this year, increasing the importance of monetizing its AI capabilities. Meta can distribute Muse through WhatsApp and eventually connect it with smart glasses. It gives the company multiple ways to expand usage and build a broader consumer AI ecosystem.
Meta has strengthened Muse's safeguards before launching the product. It could support wider use. Meta delayed the launch from April to improve security and added an autonomous safety agent that monitors Muse's actions. Users can also control which apps Muse can access, while Meta plans an encrypted version. It gives the company a path to address security concerns as it expands the product.
Muse's security failures could damage consumer trust in a product that needs access to sensitive information. Internal testing uncovered an incident in which Muse exposed private iCloud photos. Employees also reported other security concerns. Such failures could discourage users from connecting email, payment, health, and other personal accounts, limiting subscription adoption and Meta Platforms, Inc. (NASDAQ:META)'s potential revenue from Muse.

#muse

XRP ranks last for Q4 after the CLARITY Act's Senate failure removed every legislative catalyst and invalidated year-end targets built around the bill.
Ethereum leads the Q4 outlook as the only coin carrying a dated technical upgrade still on the calendar, edging out Bitcoin and crushing XRP.
Bitcoin reclaiming $80,000 before the November midterms is the single falsifiable trigger that tightens the base scenario for all three coins.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
The U.S. Senate voted 49-50 against advancing the CLARITY Act on September 15, falling eleven votes short of the 60 needed to end debate. The defeat leaves crypto's market-structure rules in the hands of the SEC and CFTC rather than Congress, at least for the remainder of 2026.

#senate #learn #september

Lucid (LCID) shares are pushing higher on Sept. 17 after the electric vehicle (EV) company announced a robotaxi partnership with European ride-hailing giant Bolt. Under the terms of this agreement, Bolt will deploy 25,000 autonomous robotaxis across Europe, using LCID's upcoming mid-size vehicle platform.
Despite today's rally, Lucid stock is down more than 60% versus the start of this year.
Why It's Time to Load Up on Nvidia Stock
ORCL Stock Layoffs: What to Know About the Latest Oracle Job Cuts
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#lucid #vehicle #despite #time

Generac Holdings (GNRC) shares ripped higher on Sept. 17 after management announced a multi-billion-dollar commercial partnership with Amazon (AMZN). In its press release, GNRC said its pivotal supply agreement with the cloud and e-commerce giant is designed to furnish backup power solutions for its expanding data center footprint.
The AMZN news brings much-needed reprieve to Generac stock that was otherwise down roughly 40% versus its year-to-date high in late June.
Why It's Time to Load Up on Nvidia Stock
ORCL Stock Layoffs: What to Know About the Latest Oracle Job Cuts
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#amzn #holdings #load

Shares of Rum Group (RUM), the company formerly known as Rumble, rallied almost 12% on Sept. 14 after The Information reported that it bagged a $13.7 billion compute deal with Anthropic. This is a major win for the company following its rebirth as Rum Group; the company now has an AI cloud and infrastructure division called Quake AI following its acquisition of Northern Data in June 2026.
The demand for compute is real and only expected to grow, irrespective of the AI slowdown fears currently engulfing the market and driving the share prices of AI companies lower. Let's take a closer look.
Why It's Time to Load Up on Nvidia Stock
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#sept #anthropic

The S&P 500 Index ($SPX) (SPY) closed down by -0.45% on Wednesday, the Dow Jones Industrial Average ($DOWI) (DIA) closed down by -1.21%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.02%. E-mini S&P futures (ESU26) fell -0.42%, and September E-mini Nasdaq futures (NQU26) rose +0.05%.
Stock indexes gave up an early advance and settled mixed on Wednesday, with the S&P 500 falling to a 6-week low, and the Dow Jones Industrials sinking to a 3-month low. The broader market retreated on Wednesday after the FOMC voted unanimously to raise interest rates by +25 bp and signaled one more rate hike later this year to contain inflation.
Why It's Time to Load Up on Nvidia Stock
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#Stock

Expedia (EXPE) shares closed meaningfully lower on Sept. 16 after a senior Morgan Stanley ******* yst, Brian Nowak, downgraded the travel technology company to "Underweight." In his research note, Nowak ******* igned a $235 price target to EXPE, indicating it could sink another 20% from current levels.
His bearish call is significant given Expedia stock has already been in a downtrend, with its price currently trailing the recent high by about 15%.
Why It's Time to Load Up on Nvidia Stock
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#Stock #morgan #brian #underweight

J.B. Hunt (JBHT) shares crashed on Sept. 16 after management issued an unexpected profit warning for the company's third financial quarter. Speaking at the Morgan Stanley Industrial Conference, leadership cautioned that operational headwinds could result in a sequential decline of as much as 10% in the firm's Q3 per-share earnings.
Including today's decline, J.B. Hunt stock is down roughly 20% versus its year-to-date high.
Why It's Time to Load Up on Nvidia Stock
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#industrial

International Business Machines (IBM) has secured a landmark $1 billion federal award from the U.S. Department of Commerce under the CHIPS and Science Act. The deal finalized non-dilutive funding to accelerate quantum wafer manufacturing at Anderon, a dedicated quantum foundry company spun out by IBM.
At the time of writing, IBM shares are down about 17% versus the start of this year.
Why It's Time to Load Up on Nvidia Stock
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#international #commerce

Nvidia (NVDA) has been powering the ongoing artificial intelligence (AI) boom. Its graphics processing units (GPUs), central processing units (CPUs), networking products, and increasingly integrated AI systems continue to benefit from enormous investments in data center infrastructure. As a result, NVDA has continued to deliver impressive financial results.
Notably, concerns about a potential slowdown in AI development have weighed on semiconductor stocks, raising fears that the enormous spending on AI infrastructure could eventually moderate. However, demand for Nvidia's products is unlikely to slow, and the company could continue delivering extraordinary growth.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#nvda #processing #units #infrastructure

For much of 2025, UnitedHealth Group (UNH) looked like a company under siege as higher medical costs and weaker margins rattled investors. UNH stock sold off sharply, and questions emerged around the company's earnings outlook as well as the health of its long-standing growth story.
That picture is starting to improve in 2026. UnitedHealth's latest results showed a clear turnaround in profitability as it generated $112 billion in revenue and $8 billion in earnings from operations. Management also raised the company's full-year adjusted EPS outlook to a range of $19.50 to $20 and increased its operating cash flow forecast to about $24 billion. Those moves suggest UnitedHealth sees its recovery as more than a short-term earnings rebound.
This High-Yield Construction Stock Just Raised Its Dividend by 40%
Dear Intuit Stock Fans, Mark Your Calendars for September 17
This Dividend Stock Is Beating the Market in 2026 and Yields 2.36%

#Stock #billion #Dividend #management

With a market cap of $48 billion, Entergy Corporation (ETR) is an energy company that generates, transmits, and distributes electricity to millions of customers across Arkansas, Louisiana, Mississippi, and Texas. The company focuses on providing reliable and affordable energy while investing in a more resilient and cleaner energy system through natural gas, nuclear, and renewable generation.
Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Entergy fits this criterion perfectly. Entergy also contributes to the communities it serves through philanthropy, volunteerism, and advocacy, reinforcing its commitment to sustainability and corporate citizenship.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#energy #company

The Baldwin Insurance Group (BWIN) is suddenly in the spotlight after Michael Dell's family office and Sequence Holdings agreed to take the insurance broker private in a deal valued at about $7.7 billion. The offer calls for $32.50 in cash for each share. That represents an 88% premium to Baldwin's unaffected June 17 closing price. Shares jumped 7.5% to $31.89 after the deal was announced on Sept. 14.
For investors, the story is now less about what Baldwin might be worth as a standalone public company and more about whether the proposed transaction closes as planned. The deal also gives Baldwin access to long-duration capital outside the public markets. That could help the company keep investing in acquisitions, technology, and artificial intelligence without the same pressure to deliver results every quarter.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#sequence

The U.S. has between 3,000 and 4,700 active data centers, with plans to build another 1,500. Globally, there are about 11,800, with plans to add about 100 gigawatts of new capacity by 2030. All of which creates substantial opportunity for beaten-down stocks such as ASML Holding (ASML). However, to run all of those data centers, the world needs advanced AI chips. Today's most advanced data-center AI processors, manufactured on 4nm, 5nm, and certain 7nm processes, depend heavily on ASML's lithography technology. And as the industry moves toward 2nm production, that dependence on ASML's EUV systems will become even more important.
Some of those companies include Samsung Electronics (SMSN.L.IX), Taiwan Semiconductor Manufacturing (TSM), and Intel (INTC). All of which are moving forward with ASML's High-Numerical Aperture extreme ultraviolet lithography systems, better known as High-NA EUV. In short, AI must have powerful chips to run. And those chips are becoming much harder to manufacture, with ASML producing the machines that make their production possible.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#asml #advanced #lithography

The S&P 500 Index ($SPX) (SPY) is up by +0.30% today, the Dow Jones Industrial Average ($DOWI) (DIA) is up by +0.05%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up by +0.68%. E-mini S&P futures (ESU26) are up +0.32%, and September E-mini Nasdaq futures (NQU26) are up +0.73%.
Stock indexes are mostly higher today. The broader market is moving higher today as a decline in crude oil prices lowers bond yields and improves market sentiment. Crude prices fell after weekly data from API late Tuesday showed US crude inventories jumped by +7.1 million bbl last week and inventories of gasoline and distillates also expanded. Crude prices added to their losses today after weekly EIA crude inventories fell less than expected and gasoline and distillate supplies increased.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
The Case for Selling CrowdStrike Stock
Dear Tesla Stock Fans, Mark Your Calendars for October 1

#crude #Stock #futures #higher

The Nasdaq 100 has rallied slightly to show signs of life as we head toward that crucial Federal Reserve interest rate decision later today. A hike of 25 basis points is expected. This is perhaps the market coming to terms with the new reality as we hold the consolidation.
The question will be whether or not Kevin Warsh sounds extraordinarily hawkish during this press conference, or if it is a situation where it is one and done. I think that probably comes into play here as well. Rates are backing off the 5% level in the 10-year at the moment, at least, but it is worth noting that the market has been extraordinarily resilient.
The Dow Jones 30 is rising a bit in the early part of the session as well. It is in the oversold part of the stochastic oscillator. It is kind of a messy look for the stochastic oscillator at the moment, but it is worth noting that the area right around 52,250 has been important and so far seems to be holding up. The 50-day EMA near the 52,700 level offers pretty significant resistance, so it could be worth watching.
The S&P 500 continues to hang around the 7,600 level. That is an area that had previously been significant resistance and now is offering a significant amount of support over the last 4 or 5 trading sessions. We also have the 50-day EMA there as well. So, a bounce from here and a recovery just means more consolidation.
It will be interesting to watch how this plays out during that press conference. It could be a volatile and ******* py session, but ultimately, the stock market has been rather resilient. The earnings calendar treated us fairly well, and the resiliency of the U.S. economy continues.

#significant #extraordinarily

Merck (MRK) was at the center of a major cancer-treatment update in August. Specifically, the drugmaker and Moderna (MRNA) said their personalized mRNA cancer therapy, intismeran autogene, delivered positive results in a Phase 3 study involving 1,137 patients with high-risk melanoma.
Used with Keytruda, the treatment reduced the risk of cancer returning or causing death and improved distant metastasis-free survival compared with Keytruda alone. Merck shares jumped 11% on the news. That was a big move for the stock, which had posted only five single-day gains of more than 5% over the past year.
This High-Yield Construction Stock Just Raised Its Dividend by 40%
Dear Intuit Stock Fans, Mark Your Calendars for September 17
This Dividend Stock Is Staging a Turnaround in 2026 and Pays More Than 2.4%

#Dividend #high #treatment #risk

Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
At the beginning of 2026, the biggest question surrounding the Federal Reserve and interest rates was whether the Fed would cut its target rate at some point this year. However, it's become increasingly clear that a rate cut won't happen any time soon. In fact, it's possible that the Fed may increase its benchmark rate before the year is over.
Following the Federal Open Market Committee (FOMC)'s most recent meeting in July, under the leadership of new Fed Chair Kevin Warsh, the committee announced its decision to maintain the target range for the federal funds rate at 3.50%-3.75%.
In its statement, the committee noted that "inflation remains elevated relative to the Committee's 2 percent goal, in part reflecting supply shocks that have driven price increases in certain sectors, including energy. The Committee will deliver price stability."
The Fed has not cut rates since late 2025, yet interest rates on consumer loans and bank accounts steadily decreased throughout 2026 — at least, until recently. Recent rate increases are a sign that the market is already pricing in a rate hike. And with a few more Fed meetings on the calendar for the remainder of 2026, consumers are wondering how potential rate changes could impact their bottom lines.

#year

Lithium Americas Corp. (LAC) is back on Wall Street's radar after JPMorgan turned bullish on the lithium developer, upgrading the stock to an "Overweight" rating from "Neutral" and setting a $6 price target. The target implies close to 100% upside from the stock's previous close, giving investors a potentially significant re-rating opportunity if the bank's bullish **** umptions play out.
The call reflects a more constructive outlook for lithium prices. JPMorgan recently raised its lithium price **** umptions, arguing that lithium carbonate prices have remained above $20 per kilogram and that the market could face a supply deficit through the end of the decade. Those higher price **** umptions materially improve JPMorgan's estimates for Lithium Americas' long-term earnings and net **** et value.
Dear **** eX Stock Fans, Mark Your Calendars for September 21
How to Play IBM Stock as It Teams Up with NASA to Launch a New Open-Source Model
GF Securities Says NAND Prices May Stabilize Later This Year. What This Means for Sandisk Stock.

#play